• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清转化生长因子-β1作为2型糖尿病肾病的生物标志物:随机对照试验的荟萃分析

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

作者信息

Mou Xin, Zhou Di-Yi, Zhou Dan-Yang, Ma Jing-Ru, Liu Ying-Hui, Chen Hui-Ping, Hu Yong-Bin, Shou Cheng-Min, Chen Jia-Wei, Liu Wen-Hong, Ma Guo-Ling

机构信息

Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China.

Zhejiang Chinese Medical University, City Road 548, Binjiang District, Hangzhou City, Zhejiang Province, 310053, China.

出版信息

PLoS One. 2016 Feb 22;11(2):e0149513. doi: 10.1371/journal.pone.0149513. eCollection 2016.

DOI:10.1371/journal.pone.0149513
PMID:26901047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4764759/
Abstract

BACKGROUND

Abnormal expression of serum TGF-β1 was found in patients with diabetic nephropathy. However, the association of TGF-β1 with the risk of diabetic nephropathy remains unknown. The present study was undertaken to investigate whether such an association exists.

METHODS

We searched the Chinese VIP, Wangfang, China National Knowledge Infrastructure, PubMed, Embase, and Google Scholar databases for relevant studies and extracted all eligible data. Stata12 software was used for statistical analysis.

RESULTS

Nine reports met our criteria and were used for data extraction. There were 264 patients and 227 healthy controls from qualified reports in this meta-analysis. The results suggested that serum TGF-β1 levels were significantly up-regulated in patients with diabetic nephropathy; the instrumental variable was 3.94 (95% confidence interval 3.20-4.68, p<0.01).

CONCLUSIONS

Meta-analysis suggested that elevated serum TGF-β level in patients with diabetes is associated with a high risk of nephropathy. Further studies are required to validate these observations.

摘要

背景

糖尿病肾病患者血清转化生长因子-β1(TGF-β1)存在异常表达。然而,TGF-β1与糖尿病肾病风险之间的关联尚不清楚。本研究旨在探讨是否存在这种关联。

方法

我们检索了中国知网、万方、维普、PubMed、Embase和谷歌学术数据库中的相关研究,并提取了所有符合条件的数据。使用Stata12软件进行统计分析。

结果

9篇报告符合我们的标准并用于数据提取。本荟萃分析中,合格报告中有264例患者和227例健康对照。结果表明,糖尿病肾病患者血清TGF-β1水平显著上调;工具变量为3.94(95%置信区间3.20-4.68,p<0.01)。

结论

荟萃分析表明,糖尿病患者血清TGF-β水平升高与肾病高风险相关。需要进一步研究来验证这些观察结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/b069d1bc0c72/pone.0149513.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/fa74fce465b3/pone.0149513.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/c7c767f2f95c/pone.0149513.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/b341084152a9/pone.0149513.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/b069d1bc0c72/pone.0149513.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/fa74fce465b3/pone.0149513.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/c7c767f2f95c/pone.0149513.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/b341084152a9/pone.0149513.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c3e/4764759/b069d1bc0c72/pone.0149513.g004.jpg

相似文献

1
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.血清转化生长因子-β1作为2型糖尿病肾病的生物标志物:随机对照试验的荟萃分析
PLoS One. 2016 Feb 22;11(2):e0149513. doi: 10.1371/journal.pone.0149513. eCollection 2016.
2
Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.2型糖尿病和糖尿病肾病患者中转化生长因子β1的变化:一项遵循PRISMA标准的系统评价和荟萃分析。
Medicine (Baltimore). 2017 Apr;96(15):e6583. doi: 10.1097/MD.0000000000006583.
3
Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.中国人群中转化生长因子-β1与2型糖尿病肾病风险的关系。
BMC Med Genet. 2018 Nov 20;19(1):201. doi: 10.1186/s12881-018-0717-3.
4
Transforming growth factor-beta 1 in diabetic nephropathy.糖尿病肾病中的转化生长因子-β1
Egypt J Immunol. 2005;12(1):103-12.
5
Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.转化生长因子β 1 和单核细胞趋化蛋白-1 作为糖尿病肾病的预后标志物。
Hum Exp Toxicol. 2013 Oct;32(10):1089-96. doi: 10.1177/0960327112470274. Epub 2013 Mar 20.
6
Activation of transforming growth factor-beta1 in diabetic kidney disease.糖尿病肾病中转化生长因子-β1的激活
Metabolism. 2000 Mar;49(3):353-9. doi: 10.1016/s0026-0495(00)90264-6.
7
Reducing serum uric acid attenuates TGF-β1-induced profibrogenic progression in type 2 diabetic nephropathy.降低血清尿酸可减轻 2 型糖尿病肾病中 TGF-β1 诱导的致纤维化进展。
Nephron Exp Nephrol. 2012;121(3-4):e109-21. doi: 10.1159/000343567. Epub 2013 Jan 9.
8
Transforming growth factor-β1 in children with diabetic nephropathy.转化生长因子-β1 在儿童糖尿病肾病中的作用。
Pediatr Nephrol. 2019 Jan;34(1):81-85. doi: 10.1007/s00467-018-4062-8. Epub 2018 Aug 22.
9
[Urine TGF-beta1 concentration in patients with type II diabetes mellitus--prognostic values].2型糖尿病患者尿转化生长因子β1浓度——预后价值
Pol Arch Med Wewn. 2002 Aug;108(2):745-52.
10
[Infect of pingshen decoction on serum HGF, Cys C and TGF-beta1 diabetic nephropathy in early stage].平肾汤对早期糖尿病肾病患者血清肝细胞生长因子、胱抑素C及转化生长因子-β1的影响
Zhongguo Zhong Yao Za Zhi. 2014 Mar;39(6):1128-31.

引用本文的文献

1
Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications.糖尿病肾病中的系膜细胞:从发病机制到治疗意义
Int J Biol Sci. 2025 Jul 24;21(11):4762-4781. doi: 10.7150/ijbs.114907. eCollection 2025.
2
Palmitate-increased TGF-β1 Gene Expression and p-Smad2/3 Protein Levels Attenuated by Chicoric Acid in Patients with Type 2 Diabetes Mellitus.在2型糖尿病患者中,棕榈酸增加的转化生长因子-β1基因表达和磷酸化Smad2/3蛋白水平被菊苣酸减弱。
Rep Biochem Mol Biol. 2025 Jan;13(4):540-548. doi: 10.61186/rbmb.13.4.540.
3
Elevated Serum SERPINE2 Levels are Linked to Impaired Renal Function in Patients with Type 2 Diabetes Mellitus.

本文引用的文献

1
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2014年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001.
2
The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.甘露糖-6-磷酸类似物PXS64通过TGF-β1途径抑制人肺成纤维细胞中的纤维化。
Immunol Lett. 2015 Jun;165(2):90-101. doi: 10.1016/j.imlet.2015.04.003. Epub 2015 Apr 27.
3
UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses.
血清丝氨酸蛋白酶抑制剂E2(SERPINE2)水平升高与2型糖尿病患者肾功能受损有关。
Diabetes Ther. 2025 Jun;16(6):1313-1326. doi: 10.1007/s13300-025-01742-7. Epub 2025 Apr 29.
4
Novel Dietary Inflammatory Score and Risk of Incident CKD.新型饮食炎症评分与慢性肾脏病发病风险
Clin J Am Soc Nephrol. 2025 Apr 1;20(4):485-494. doi: 10.2215/CJN.0000000635. Epub 2025 Feb 17.
5
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy.利用多酚的力量:疾病预防与治疗的新前沿。
Pharmaceuticals (Basel). 2024 May 27;17(6):692. doi: 10.3390/ph17060692.
6
Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions.糖尿病并发症中的炎症:分子机制与治疗干预
MedComm (2020). 2024 Apr 12;5(4):e516. doi: 10.1002/mco2.516. eCollection 2024 Apr.
7
Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy.不同免疫细胞在高血压肾病中炎症调节的机制。
Front Immunol. 2024 Mar 13;15:1333170. doi: 10.3389/fimmu.2024.1333170. eCollection 2024.
8
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes.抗氧化植物化学物质对 2 型糖尿病的潜在益处。
Molecules. 2023 Oct 21;28(20):7209. doi: 10.3390/molecules28207209.
9
Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease.糖尿病肾病中系膜细胞和肾小管上皮细胞的细胞串扰。
Cell Commun Signal. 2023 Oct 16;21(1):288. doi: 10.1186/s12964-023-01323-w.
10
Folate Deficiency Enhanced Inflammation and Exacerbated Renal Fibrosis in High-Fat High-Fructose Diet-Fed Mice.叶酸缺乏增强高脂肪高果糖饮食喂养小鼠的炎症反应并加重肾纤维化。
Nutrients. 2023 Aug 17;15(16):3616. doi: 10.3390/nu15163616.
英国肾脏注册处第17份年度报告:第1章 2013年英国肾脏替代治疗发病率:全国及各中心分析。
Nephron. 2015;129 Suppl 1:1-29. doi: 10.1159/000370271. Epub 2015 Jan 22.
4
Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.血清转化生长因子-β1水平可能在胃癌患者中具有预测和预后作用。
Tumour Biol. 2015 Mar;36(3):2097-103. doi: 10.1007/s13277-014-2817-9. Epub 2014 Nov 13.
5
The effect of transforming growth factor β1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation.血清剥夺条件下转化生长因子β1对纤维环细胞自噬与凋亡之间相互作用的影响
Cytokine. 2014 Dec;70(2):87-96. doi: 10.1016/j.cyto.2014.07.249. Epub 2014 Aug 13.
6
Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathway.层粘连蛋白α1通过转化生长因子-β途径调节与年龄相关的系膜细胞增殖和系膜基质积聚。
Am J Pathol. 2014 Jun;184(6):1683-94. doi: 10.1016/j.ajpath.2014.02.006. Epub 2014 Apr 8.
7
Association of transforming growth factor-β1 T869C gene polymorphism with diabetic nephropathy risk.转化生长因子-β1基因T869C多态性与糖尿病肾病风险的关联。
Nephrology (Carlton). 2014 Feb;19(2):107-15. doi: 10.1111/nep.12176.
8
A meta-analysis of the association of G915C, G800A, C509T gene polymorphism of transforming growth factor-β1 with diabetic nephropathy risk.转化生长因子-β1基因G915C、G800A、C509T多态性与糖尿病肾病风险关联的荟萃分析。
Ren Fail. 2014 Mar;36(2):321-6. doi: 10.3109/0886022X.2013.832320. Epub 2013 Sep 24.
9
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.非诺贝特通过抑制核因子-κB 和转化生长因子-β1/Smad3 减轻糖尿病肾病的肾小管间质纤维化和炎症。
Exp Biol Med (Maywood). 2010 Mar;235(3):383-91. doi: 10.1258/ebm.2009.009218.
10
Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy.α-硫辛酸对糖尿病肾病中转化生长因子β1-p38丝裂原活化蛋白激酶-纤连蛋白通路的影响
Metabolism. 2009 May;58(5):616-23. doi: 10.1016/j.metabol.2008.12.006.